Anniina Snellman

TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis (2026)

Multiple Sclerosis

Saraste Maija; Nikkilä Taru; Matilainen Markus; Hämäläinen Päivi; Wahlroos Saara; Rajander Johan; Snellman Anniina; Rinne Juha; Airas Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals (2026)

Alzheimer's Research and Therapy

Koivumäki, Mikko; Martiskainen, Henna; Takalo, Mari; Lehtisalo, Jenni; Ngandu, Tiia; FinnGen; Snellman, Anniina; Hiltunen, Mikko; Rinne, Juha O.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Midlife insulin resistance and brain beta-amyloid accumulation as predictors of change in late-life cognitive function – A 20-year follow-up study (2026)

Neurobiology of Aging

Pietilä, Elina; Karrasch, Mira; Helin, Semi; Snellman, Anniina; Viitanen, Matti; Jula, Antti; Rinne, Juha O.; Ekblad, Laura L.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Associations of 18 F‐RO‐948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum (2026)

Alzheimer's and Dementia

Shekari, Mahnaz; González Escalante, Armand; Milà‐Alomà, Marta; Falcon, Carles; López‐Martos, David; Sánchez‐Benavides, Gonzalo; Brugulat‐Serrat, Anna; Niñerola‐Baizán, Aida; Ashton, Nicholas J.; Karikari, Thomas K.; Lantero‐Rodriguez, Juan; Montoliu‐Gaya, Laia; Snellman, Anniina; Day, Theresa A.; Dage, Jeffrey L.; Ortiz‐Romero, Paula; Tonietto, Matteo; Borroni, Edilio; Klein, Gregory; Kollmorgen, Gwendlyn; Carboni, Margherita; Quijano‐Rubio, Clara; Vanmechelen, Eugeen; Minguillón, Carolina; Fauria, Karine; Perissinotti, Andrés; Molinuev,o José Luis; Zetterberg, Henrik; Blennow, Kaj; Grau‐Rivera, Oriol; Suárez‐Calvet, Marc; Gispert, Juan Domingo; ALFA Study

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

APOE4 carriership status influences [11C]PiB white matter retention in cognitively healthy older adults (2025)

Neurobiology of Disease

Tato-Fernández Claudia; Ekblad Laura L.; Bucci Marco; Tuisku Jouni; Parkkola Riitta; Helin Semi; Rinne Juha O.; Snellman Anniina

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Exploring Associations Between Longitudinal [18F]RO-948 Tau PET, Baseline Fluid tau Biomarkers, and memory in the Early Alzheimer's Disease continuum (2025)

Alzheimer's and Dementia

Shekari, Mahnaz; González Escalante, Armand; López‐Martos, David; Milà‐Alomà, Marta; Sánchez‐Benavides, Gonzalo; Brugulat‐Serrat, Anna; Niñerola‐Baizán, Aida; Falcon, Carles; Ashton, Nicholas J.; Karikari, Thomas; Rodriguez, Juan Lantero; Snellman, Anniina; Day, Theresa A.; Dage, Jeffrey L.; Ortiz‐Romero, Paula; Tonietto, Matteo; Klein, Gregory; Kollmorgen, Gwendlyn; Quijano‐Rubio, Clara; Vanmechelen, Eugeen; Minguillón, Carolina; Fauria, Karine; Perissinotti, Andrés; Molinuevo, Jose Luis; Zetterberg, Henrik; Blennow, Kaj; Salvadó, Gemma; Grau‐Rivera, Oriol; Vállez‐Garcia, David; Suárez‐Calvet, Marc; Gispert, Juan Domingo; ALFA+ study

(Konferenssiposteri)

Synaptic Density in Multiple Sclerosis (2025)

Neurology, Neuroimmunology and Neuroinflammation

Luoma, Amelie; Matilainen, Markus; Tuisku, Jouni Mikael; Aarnio, Richard; Nikkilä, Taru; Laaksonen, Sini; Koivumäki, Mikko; Honkonen, Eveliina; Nylund, Marjo; Wahlroos, Saara; Solin, Olof; Chen, Ming-Kai; Toyonaga, Takuya; Lehto, Jussi; Snellman, Anniina; Rinne, Juha O.; Airas, Laura M.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease (2024)

Acta Neuropathologica

Lantero-Rodriguez J., Montoliu-Gaya L., Benedet A.L., Vrillon A., Dumurgier J., Cognat E., Brum W.S., Rahmouni N., Stevenson J., Servaes S., Therriault J., Becker B., Brinkmalm G., Snellman A., Huber H., Kvartsberg H., Ashton N.J., Zetterberg H., Paquet C., Rosa-Neto P., Blennow K.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)

EJNMMI Research

Alzghool Obada M., Aarnio Richard, Helin Jatta S., Wahlroos Saara, Keller Thomas, Matilainen Markus, Solis Junel, Danon Jonathan J., Kassiou Michael, Snellman Anniina, Solin Olof, Rinne Juha O., Haaparanta‑Solin Merja

(O2 Muu julkaisu )

Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)

Frontiers in Neurology

Laaksonen Sini, Saraste Maija, Nylund Marjo, Hinz Rainer, Snellman Anniina, Rinne Juha, Matilainen Markus, Airas Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Anniina

Snellman

Contact

Links

Publications

Sort by:

TSPO-PET-measurable neuroinflammation associates with information processing speed decline in multiple sclerosis (2026)

Genetic validation of ABI3 p.Ser209Phe variant and its effects on early brain pathology in asymptomatic elderly individuals (2026)

Midlife insulin resistance and brain beta-amyloid accumulation as predictors of change in late-life cognitive function – A 20-year follow-up study (2026)

Associations of 18 F‐RO‐948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum (2026)

APOE4 carriership status influences [11C]PiB white matter retention in cognitively healthy older adults (2025)

Exploring Associations Between Longitudinal [18F]RO-948 Tau PET, Baseline Fluid tau Biomarkers, and memory in the Early Alzheimer's Disease continuum (2025)

Synaptic Density in Multiple Sclerosis (2025)

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease (2024)

Correction to: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA (EJNMMI Research, (2024), 14, 1, (25), 10.1186/s13550-024-01085-7) (2024)

Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals (2024)